DecisionView develops web-based software solutions that enable life sciences organizations to improve clinical trial performance. DecisionView's flagship solution, StudyOptimizer, is a web-based solution that helps clinical trial organizations plan, forecast and track patient enrollment. DecisionView Enrollment Benchmarks aggregate cross-industry performance data from clinical trials that have completed enrollment, providing insight to enable more realistic planning and forecasting. In April 2012, DecisionView was acquired by IMS Health. The valuation of DecisionView was undisclosed. Other terms of the deal were not released.
Expert Collections containing DecisionView
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
DecisionView is included in 1 Expert Collection, including Digital Health.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Latest DecisionView News
Nov 7, 2018
Company Also Expands Advisory Board with Two New Members News provided by Share this article PALO ALTO, Calif., Nov. 7, 2018 /PRNewswire/ -- Cardinal Analytx Solutions, a developer of advanced machine learning solutions for improving healthcare while reducing costs by predicting impending medical conditions, today announced it has hired healthcare veteran Linda T. Hand as CEO to lead the company through its next phase of growth. Formerly president and CEO of DecisionView, Hand joins Cardinal Analytx at a pivotal time of significant company momentum, with two new advisors also coming aboard. "We are delighted to have Linda as our partner in turning the science pioneered at Stanford into better care for patients," said Cardinal Analytx co-founder Dr. Nigam Shah, a Stanford professor of medicine and biomedical data science, and an expert on applying machine learning to healthcare problems. Shaw, who also co-directs Stanford's Center for Biomedical Informatics Research, created Cardinal Analytx with his co-founder Dr. Arnie Milstein, a nationally recognized managed care expert who directs the Clinical Excellence Research Center and teaches at the Stanford University School of Medicine. Hand joins Cardinal Analytx with 35 years of experience in organizational leadership, product development, solutions delivery and go-to-market strategies across a diverse portfolio of industries, and has provided management consulting services to several emerging enterprises and venture capital firms. She brings deep experience in both healthcare and technology to her new role. Previously, she led the Clinical Trial Optimization Solutions division at IQVIA. Prior to that, she spent more than seven years with DecisionView, the leading provider of clinical trial enrollment optimization solutions, acquired by IMS Health in 2012. Hand also ran product development and delivery at leading software companies, including DigitalThink, Hyperion, Arbor Software and Sybase. "I'm genuinely excited to be taking this role at such an opportune time. Cardinal Analytx is on the cusp of significant growth with greater market penetration and an expanded suite of offerings," said Hand, who is responsible for leading the company at its Palo Alto headquarters. "I'm also honored to be joining the stellar team that is advising, supporting and delivering the Cardinal Analytx vision and mission." Supporting New CEO, Cardinal Analytx Adds Advisors Cardinal Analytx also announced two new advisors, Virginia McFerran and Colt Courtright. McFerran and Courtright bring a vast array of experience in the healthcare industry and the use of information technologies and data analytics to improve and expand Cardinal Analytx's suite of offerings. McFerran is a former partner at Optum Ventures and president and CEO of Optum Analytics. She has over 20 years' experience in digital health technologies and has also served as CIO at UCLA Health and Weill Cornell Medical Center. Courtright is director of Corporate Data and Analytics at Premera Blue Cross, responsible for strategies affecting 2.1 million members, a physician network of 38,000 and self-insured employers including Amazon, Microsoft, Expedia and other major corporations. He has significant experience developing new product innovation, supporting strategic partnerships, and overseeing advanced analytics and data management solutions, as well as new product deployments. Cardinal Analytx unveiled its Board of Directors and Advisory Board in January. Since then, the company's senior leadership team, including Afsana Akhter, Brain Maples and Miguel Pating, have grown the team to 22 members in Silicon Valley. About Cardinal Analytx Solutions Based in Palo Alto, Calif., Cardinal Analytx Solutions is an early-stage predictive analytics company that leverages machine learning and AI technology to identify potential high-expense health plan enrollees and provide targeted clinical recommendations designed to improve patient outcomes and contain costs. The company, which was spun out of Stanford University-affiliated StartX startup accelerator, is backed by Cardinal Partners, Premera Blue Cross and the Stanford-StartX Fund. Founded by two Stanford industry luminaries in medicine and biomedical data science, Drs. Arnie Milstein and Nigam Shah, Cardinal Analytx is committed to transforming patient lives by combining machine learning with clinical excellence. For more information, visit www.cardinalanalytx.com or email email@example.com . SOURCE Cardinal Analytx Solutions
DecisionView Frequently Asked Questions (FAQ)
When was DecisionView founded?
DecisionView was founded in 2002.
Where is DecisionView's headquarters?
DecisionView's headquarters is located at 301 Howard St, San Francisco.
What is DecisionView's latest funding round?
DecisionView's latest funding round is Acquired.
How much did DecisionView raise?
DecisionView raised a total of $14.73M.
Who are the investors of DecisionView?
Investors of DecisionView include IMS Health, Granite Ventures, Adobe Ventures, Aeris Capital, Partech Partners and 4 more.